These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2821580)

  • 1. Chemotherapeutic agents for herpesvirus infections.
    De Clercq E; Walker RT
    Prog Med Chem; 1986; 23():187-218. PubMed ID: 2821580
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral Research--16th International Conference: 27 April-1 May 2003, Savannah, GA, USA.
    Vere Hodge A
    IDrugs; 2003 Jun; 6(6):512-4. PubMed ID: 12861972
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiviral agents for the systemic treatment of herpesvirus infections].
    Degré M
    Tidsskr Nor Laegeforen; 1991 Sep; 111(21):2663-4. PubMed ID: 1658971
    [No Abstract]   [Full Text] [Related]  

  • 4. [New approaches to the chemotherapy of herpesvirus infections].
    Chizhov NP; Golovina GI; Iurlova TI; Briazzhikova TS
    Antibiot Khimioter; 1993; 38(10-11):75-82. PubMed ID: 8085898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 6. [New medication for herpesvirus infections].
    Vesikari T
    Duodecim; 1995; 111(8):680, 683-4. PubMed ID: 8681827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histolical background of herpesvirus infections and antiviral drugs].
    Shimada K
    Nihon Rinsho; 1989 Feb; 47(2):245-51. PubMed ID: 2542643
    [No Abstract]   [Full Text] [Related]  

  • 8. Subclinical shedding of HSV: its potential for reduction by antiviral therapy.
    Corey L; Wald A; Davis LG
    Adv Exp Med Biol; 1996; 394():11-6. PubMed ID: 8815678
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and potential treatments for ubiquitous but neglected herpesvirus infections.
    Gable JE; Acker TM; Craik CS
    Chem Rev; 2014 Nov; 114(22):11382-412. PubMed ID: 25275644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiviral action and pathogenetic targets for seaweed sulfated polysaccharides in herpesvirus infections].
    Besednova NN; Makarenkova ID; Zvyagintseva TN; Imbs TI; Somova LM; Zaporozhets TS
    Biomed Khim; 2016 Mar; 62(3):217-27. PubMed ID: 27420612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The principles of the pathogenetic antiherpetic chemotherapy of acute and recurrent herpesvirus infections].
    Khakhalin LN; Abazova FI
    Ter Arkh; 1995; 67(1):55-9. PubMed ID: 7709360
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral therapy for feline herpesvirus infections.
    Maggs DJ
    Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1055-62. PubMed ID: 20933135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of viruses to antiviral drugs.
    Freifeld AG; Ostrove JM
    Annu Rev Med; 1991; 42():247-59. PubMed ID: 1852148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [History of herpesvirus research].
    Nishiyama Y
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():7-12. PubMed ID: 16615432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in chemotherapeutic agents--antiviral agents].
    Morishima T
    Nihon Rinsho; 1986 Apr; 44(4):852-7. PubMed ID: 3020270
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets.
    Coen DM; Schaffer PA
    Nat Rev Drug Discov; 2003 Apr; 2(4):278-88. PubMed ID: 12669027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the management of herpesvirus infections. Introduction.
    Whitley RJ
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):1-3. PubMed ID: 8840409
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy.
    Crum-Cianflone NF; Wallace MR; Looney D
    AIDS; 2006 Jul; 20(11):1567-9. PubMed ID: 16847420
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of persistent active herpesvirus infections.
    Straus SE
    J Virol Methods; 1988 Sep; 21(1-4):305-13. PubMed ID: 2846620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
    Jacobson MA
    AIDS Clin Rev; 1992; ():173-89. PubMed ID: 1318736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.